The Company was established in May 2004 in China with a registered capital of $8mn. It specializes in the production of Garlicin, Ametryn and Prometryn and is regarded as the top producer for the three products in China, controlling a range of 20% to 80% of the respective domestic market share. The Company has 160 full time employees.
In the past three years, the Company has experienced steady growth in its revenue and net income, at a rate of 39% and 36% respectively, allowing the Company to achieve $22.6mn in revenue and $2.62mn net income in the year 2012.
$20mn debt financing at 12%.
Use of Proceeds:
Existing Plant Expansion: Addition of Production Line: $3mn
Establishment of Trading Company: $1mn
Working Capital & Production Cost: $4mn
Acquisition of Supplier Plant: $10mn
Professional Fees: $2mn
The Company intends to introduce new production lines into the existing facility to meet the demand of the market. Once completed, the Company anticipates it will generate as much as $32mn in revenue.
Management plans to acquire a plant from the supplier chemical industry. Upon acquisition, there will be additional production facility to meet current demand plus generate additional revenues from supplier business scope. The plant will generate additional $15m sales after completion of acquisition in 2014.
Due to market's supply shortage, management will establish a chemical pesticide trading company in 2014, which will result in $3mn to$5mn in additional sales.
Revenues & EBITDA in USD
2015 87mn 18mn
2014 60mn 12mn
2013 27mn 5.5mn
2012 22.6mn 4.67mn